| FDA | Food and Drug Administration |
| FGF1 | Fibroblast growth factor 1 |
| FGF2 | fibroblast growth factor 2 |
| FGFR1 | Fibroblast growth factor receptor 1 |
| GAPDH | Glyceraldehyde 3-phosphate dehydrogenase |
| IgG | Immunoglobulin G: IHC: Immuno HistoChemistry |
| LATS1 | Large tumor suppressor kinase 1 |
| MDA Pca | MD Anderson Prostate Cancer |
| MET | Mesenchymal to Epithelial Transition |
| MST1/2 | Mammalian Ste20-like kinases 1/2 |
| NOD/SCID | non-obese diabetic/severe combined immune deficiency |
| PBS | phosphate buffered saline |
| PCR | Polymerase chain reaction |
| qRT-PCR | Quantitative Real-Time Polymerase Chain Reaction |
| RPMO | Roswell Park Memorial Institute |
| sh-c-Met | Short hairpin-C-MET |
| TKI | Tyrosine kinase inhibitors |
| TBX5 | T-Box Transcription Factor 5 |
| VEGFR2 | Vascular endothelial growth factor receptor 2 |
| YAP | Yes-associated protein 1 |